IRIS UniCatt

Pinto, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.232
NA - Nord America 6.174
AS - Asia 4.102
SA - Sud America 736
AF - Africa 153
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
AN - Antartide 1
Totale 31.433
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 14.169
US - Stati Uniti d'America 5.991
DE - Germania 1.920
SG - Singapore 1.896
CN - Cina 916
NL - Olanda 861
SE - Svezia 787
FR - Francia 603
BR - Brasile 583
UA - Ucraina 471
VN - Vietnam 344
GB - Regno Unito 328
PL - Polonia 297
IN - India 237
IE - Irlanda 184
ID - Indonesia 129
FI - Finlandia 116
RU - Federazione Russa 115
CA - Canada 109
JP - Giappone 102
HK - Hong Kong 94
CH - Svizzera 93
TR - Turchia 67
BE - Belgio 62
ES - Italia 57
BD - Bangladesh 56
AR - Argentina 52
MX - Messico 40
ZA - Sudafrica 36
IQ - Iraq 35
EC - Ecuador 25
MA - Marocco 25
CI - Costa d'Avorio 23
PK - Pakistan 23
IR - Iran 22
AL - Albania 20
AT - Austria 19
JO - Giordania 19
CO - Colombia 18
VE - Venezuela 18
RO - Romania 17
AU - Australia 16
AE - Emirati Arabi Uniti 15
KR - Corea 15
LT - Lituania 15
SA - Arabia Saudita 15
AZ - Azerbaigian 14
MY - Malesia 14
CZ - Repubblica Ceca 13
PH - Filippine 13
NG - Nigeria 12
UZ - Uzbekistan 12
CL - Cile 11
EG - Egitto 11
EU - Europa 11
GR - Grecia 11
HU - Ungheria 11
PY - Paraguay 11
PE - Perù 10
TW - Taiwan 9
BZ - Belize 8
KE - Kenya 8
TH - Thailandia 8
TN - Tunisia 8
BG - Bulgaria 7
LB - Libano 7
DK - Danimarca 6
SN - Senegal 6
CR - Costa Rica 5
ET - Etiopia 5
IL - Israele 5
NP - Nepal 5
PT - Portogallo 5
SM - San Marino 5
UY - Uruguay 5
BY - Bielorussia 4
DZ - Algeria 4
HR - Croazia 4
KZ - Kazakistan 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
BO - Bolivia 3
CV - Capo Verde 3
IS - Islanda 3
JM - Giamaica 3
KG - Kirghizistan 3
KW - Kuwait 3
LU - Lussemburgo 3
LV - Lettonia 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 31.391
Salva come PNG Salva come JPEG
Città #
Milan 1.387
Rome 1.202
Singapore 1.026
Chandler 914
Ashburn 563
San Jose 543
Naples 409
Florence 259
Turin 250
Jacksonville 246
Bologna 206
Beijing 204
Warsaw 203
San Mateo 191
Los Angeles 179
Dublin 177
Ann Arbor 176
Palermo 171
Bari 167
Wilmington 143
Catania 136
Ho Chi Minh City 126
Nanjing 125
Genoa 123
Verona 112
Jakarta 111
Lauterbourg 110
Houston 109
Nürnberg 107
Dearborn 103
New York 96
Woodbridge 94
Munich 89
Hong Kong 84
Hanoi 83
The Dalles 82
Boston 77
Fairfield 77
Frankfurt am Main 77
Nanchang 75
Bremen 70
São Paulo 70
Brescia 66
Chicago 63
Lawrence 62
Kraków 60
Padova 60
Tokyo 58
Seattle 54
Cagliari 53
Redwood City 53
Venice 53
Moscow 52
Cattolica 50
Hefei 50
Parma 48
Brussels 47
Dallas 46
Taranto 46
Pescara 43
Princeton 42
Bergamo 41
Ottawa 41
Reggio Emilia 41
Perugia 40
Messina 39
Paris 39
Marseille 38
Salerno 36
Livorno 35
Lancaster 34
Santa Clara 34
Amsterdam 33
Helsinki 32
Mountain View 32
Council Bluffs 31
Izmir 30
Redmond 30
Falls Church 29
Lucca 29
Modena 29
Buffalo 28
Kadoma 28
Trieste 28
Kunming 27
Montreal 26
Monza 26
Novara 26
Augusta 25
Cambridge 25
Rimini 25
Brooklyn 24
Tianjin 24
Abidjan 23
London 23
Hyderabad 21
Johannesburg 21
Orem 21
Rio de Janeiro 21
Toronto 21
Totale 12.914
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.944
Iniezione transuretrale intracervicale di tossina botulinica tipo A nel trattamento della dissinergia del collo vescicale refrattaria a terapia medica 1.221
Iniezione intracervicale di OnabotulinotossinaA per il trattamento dell'ostruzione primitiva del collo vescicale refrattaria alla terapia medica. Una nuova opzione terapeutica 943
Ruolo della risonanza magnetica funzionale (DCE-MRI, DWI-MRI)in pazienti sottoposti a saturation biopsy per persistente sospetto di carcinoma prostatico nonostante un primo set bioptico negativo: risultati preliminari su esperienza monocentrica 909
Il ruolo della chemioimmunoterapia endovescicale nella neoplasia della vescica non muscolo invasiva “ non responder” 610
La tecnologia robotica nel contesto urologico italiano: analisi economica costo-efficacia 427
MALAT1 and HOTAIR long non-coding RNAs play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells 415
High intensity focused ultrasound (HIFU) in prostate cancer: today’s outcomes and tomorrow’s perspectives 357
Studio trasversale sui sintomi e sulle complicanze del basso apparato urinario e sul loro impatto sulla qualità  della vita connessa alla salute (HRQL) in una coorte di pazienti con sclerosi multipla (MS) utilizzando questionari standardizzati 326
Efficacia di un programma supervisionato perioperatorio di fisioterapia del pavimento pelvico per il miglioramento del recupero della continenza dopo prostatectomia radicale: trial randomizzato controllato 324
High-intensity focused ultrasound in prostate cancer: Today's outcomes and tomorrow's perspectives 317
Pros-IT CNR: an Italian prostate cancer monitoring project 282
H19-Dependent Transcriptional Regulation of β3 and β4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer. 274
E-CADHERIN AND IL-6 SERUM LEVELS IN PATIENTS AFFECTED BY PROSTATE CANCER BEFORE AND AFTER PROSTATECTOMY 262
Le infezioni delle vie urinarie 252
Efficacy of a supervised low-intensity regimen of perioperative pelvic floor muscle training in reducing postprostatectomy urinary incontinence: A randomized controlled trial 248
Do testis germinal tumours express PTTG (Pituitary Transforminf Tumour Gene) 237
Metabolic reprogramming by malat1 depletion in prostate cancer 226
URINARY PROTEOMICS IN RENAL CELL CANCER BY MALDI-TOF MASS SPECTROMETRY:A PRELIMINARY CONTROLLED STUDY 216
SEXUAL DYSFUNCTIONS IN PATIENTS AFFECTED BY MULTIPLE SCLEROSIS: EVALUATION IN A CONTEMPORARY COHORT FROM A REFERRAL CENTER 216
Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma 202
The occult urothelial cancer 199
Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy 197
OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes 193
Robot technology in the Italian Health-CARE system: cost-efficacy economic analysis 184
Complications of Extracorporeal Shock Wave Lithotripsy for Urinary Stones: To Know and to Manage Them–A Review 183
Role of SOCS3 evaluated by immunohistochemical analysis in a cohort of patients affected by prostate cancer: preliminary results 183
Male infertility: non-surgical therapy 179
Silencing of GSTP1, a prostate cancer prognostic gene, by the estrogen receptor-β and endothelial nitric oxide synthase complex 173
Human factors in surgery: from Three Mile Island to the operating room 171
[Overactive bladder syndrome: the social and economic perspective] 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia treated with intraprostatica onabotulinumtoxinA: 3 month results of a prospective single-armed cohort study 169
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study 168
Imaging in prostate cancer diagnosis: present role and future perspectives 167
Size of Bladder Cancers: Correlation among Different Types of Measurement 167
Bladder and prostate metastasis from small cell lung cancer: a rare entity 167
Children with special health care needs attending emergency department in Italy: analysis of 3479 cases 166
Hot topics in urological health economics. A mini review 165
Therapeutic strategies in penile cancer: state of the art 162
Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review 161
Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial 160
(99m)Tc-Mag3 Diuretic Renography In Assessment Of Obstructive Uropathy. The New Test F+10sp: A Step Ahead In The Differential Diagnosis 160
IMAGING IN BLADDER CANCER: PRESENT ROLE AND FUTURE PERPECTIVES.Totaro A, Pinto F, Brescia A, Racioppi M, Cappa E, D'Agostino D, Volpe A, Sacco E, Palermo G, Valentini AL, Bassi PF. 160
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 160
L' era del PCA3: risultati preliminari di uno studio pragmatico monocentrico 158
Treatment of bladder neck dissynergia with transurethral injection of OnabotulinumtoxinA: objective and patient-reported results 156
Brachytherapy in men with prostate cancer: update on indications and outcomes 156
Advanced bladder cancer: New agents and new approaches. A review 155
Imaging of renal cell carcinoma: state of the art and recent advances 154
Imaging in prostate cancer staging: present role e future perspectives 153
Hifu as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 152
Circulating tumor cells as prognostic biological marker in different stages prostate cancer and the effect of different therapeutic approaches on their expression 150
H19-Dependent Transcriptional Regulation of beta 3 and beta 4 Integrins Upon Estrogen and Hypoxia Favors Metastatic Potential in Prostate Cancer 148
Advanced bladder cancer: New agents and new approaches. A review 147
Clinical, pathological and molecular prognostic factors in prostate cancer decision-making process 144
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 143
Local relapse of prostate cancer after primary definitive treatment: the management 143
Imaging in prostate cancer staging: present role and future perspectives 142
Circumcision: history, religion and law 140
Thermochemotherapy for non-muscle-invasive bladder cancer: is there a chance to avoid early cystectomy? 140
Imaging in Prostate Cancer Diagnosis: Present Role and Future Perspectives. 140
Epigenetic silencing of SOCS3 identifies a subset of prostate cancer with an aggressive behavior 139
Inhibition of prostate efferent neurotransmission by amikacin 139
High intensity focused ultrasound as first line salvage therapy in prostate cancer local relapse after radical prostatectomy: 4-year follow-up outcomes 139
Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy 137
Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms 136
Imaging of renal cell carcinoma: state of the art and recent advances 132
Value of Current Chemotherapy and Surgery in Advanced and Metastatic Bladder Cancer 131
The occult urothelial cancer 130
Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer 129
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging-Hystopatology correlations 124
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: results from an Italian, prospective, observational study (the Pros-IT CNR study) 124
Titanised Transobturator Sling Placement for Male Stress Urinary Incontinence Using an Inside-Out Single-Incision Technique: Minimum 12-Months Follow-Up Study 122
Imaging in prostate cancer diagnosis: present role and future perspectives 121
Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. 117
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging–Hystopatology correlations 112
Anti-anginal drugs: Systematic review and clinical implications 108
Predictive Factors for Major Complications and Urological Cancer Diagnosis in Older Adults (≥80 Years) Admitted to the Emergency Department for Hematuria 105
A circulating miRNA assay as a first-line test for prostate cancer screening 105
Imaging of renal cell carcinoma: state of the art and recent advances. 104
Intraprostatic botulinum toxin type "A" injection in patients with benign prostatic hyperplasia and unsatisfactory response to medical therapy: A randomized, double-blind, controlled trial using urodynamic evaluation 103
Sports and Genitourinary Traumas 103
Prognostic Impact of H19/Cell Adhesion Molecules Circuitry on Prostate Cancer Biopsy 102
A circulating miRNA assay as a first-line test for prostate cancer screening 102
[Doping and urologic tumors] 102
T2-weighted hypointense lesions within prostate gland: Differential diagnosis using wash-in rate parameter on the basis of dynamic contrast-enhanced magnetic resonance imaging—Hystopatology correlations 100
Clinical Significance of Perinephric Fluid Collection in Patients with Renal Colic and Urolithiasis: A Retrospective Analysis 99
Rate of clinically significant prostate cancer on repeat saturation biopsy after a diagnosis of atypical small acinar proliferation 98
The cost of treatment and follow-up of bladder cancer in Italy 97
[Prostatitis syndromes and sporting activities] 96
Immediate ileal ureter replacement for ureteral avulsion during ureterescopy 96
Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy 94
Anti-Anginal drugs-beliefs and evidence: Systematic review covering 50 years of medical treatment 94
[Continuing evolution of statistical tests in medical research] 92
Mechanisms of Resistance to Second-Generation Antiandrogen Therapy for Prostate Cancer: Actual Knowledge and Perspectives 91
Circumcision: history, religion and law 89
[Sport, infertility and erectile dysfunction] 87
Shock-wave lithotripsy or ureterorenoscopy for renal stones? 83
[Androgen-deprivation therapy in prostate cancer: clinical evidence and future perspectives] 83
Bladder tumor markers: A review of the literature 72
Totale 30.929
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.961
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 0 0 0 0 0 187 72
2021/20221.427 126 90 62 119 111 77 66 181 102 102 177 214
2022/20233.938 364 344 266 461 187 407 173 316 428 255 417 320
2023/20245.910 321 534 389 462 453 452 481 587 430 582 561 658
2024/20257.927 596 683 721 649 777 592 632 638 841 577 666 555
2025/20266.724 1.029 354 471 657 1.054 432 1.253 434 491 487 62 0
Totale 31.684